Bering Partners II, L.P. - 05 Sep 2025 SCHEDULE 13G Report for Coherus Oncology, Inc. Common Stock, $0.0001 par value per share (CHRS)

Filing Manager
Bering Partners II, L.P.
Reporting Manager
Evgeny Zaytsev ("Zaytsev")
Security
Coherus Oncology, Inc. Common Stock, $0.0001 par value per share
Symbol
CHRS
Shares outstanding
116,964,738 shares
Disclosed Ownership
7,602,708 shares
Ownership
6.5%
Form type
SCHEDULE 13G
Filing time
04 Nov 2025, 18:44:44 UTC
Date of event
05 Sep 2025
SEC
View on sec.gov

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Bering Partners II, L.P. ("Bering II") 4.1% 4,763,062 4,763,062 0 /s/ Evgeny Zaytsev Managing Member of the General Partner
Bering Partners II GP, L.L.C. ("Bering II GP") 4.1% 4,763,062 4,763,062 0 /s/ Evgeny Zaytsev Managing Member
Bering Partners III, L.P. ("Bering III") 2.4% 2,826,446 2,826,446 0 /s/ Evgeny Zaytsev Managing Member of the General Partner
Bering Partners III GP, L.L.C. ("Bering III GP") 2.4% 2,826,446 2,826,446 0 /s/ Evgeny Zaytsev Managing Member
Evgeny Zaytsev ("Zaytsev") 6.5% 7,602,708 13,200 7,589,508 /s/ Evgeny Zaytsev Evgeny Zaytsev
Philip Sawyer ("Sawyer") 6.5% 7,589,508 0 7,589,508 /s/ Philip Sawyer Philip Sawyer